Tarsus Pharmaceuticals Financial Health
How is Tarsus Pharmaceuticals's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: TARS's short term assets ($250.3M) exceed its short term liabilities ($11.7M).
Long Term Liabilities: TARS's short term assets ($250.3M) exceed its long term liabilities ($19.6M).
Debt to Equity History and Analysis
Debt Level: TARS has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TARS's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TARS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: TARS has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 16.9% each year